(Q40434262)

20 September 2017

1 reference

title

Epidermal cytokines in allergic contact dermatitis (English)

1 reference

20 September 2017

S. Kondo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593779

1 June 2024

D. N. Sauder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7593779

1 June 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0190962295918175?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

https://api.elsevier.com/content/article/PII:0190962295918175?httpAccept=text/plain

1 June 2024

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Journal of the American Academy of Dermatology

1 June 2024

published in

1 reference

20 September 2017

volume

33

1 reference

20 September 2017

issue

5 Pt 1

1 reference

20 September 2017

page(s)

786-800

1 reference

Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein

20 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Subclustering of CD1 monoclonal antibodies based on the reactivity on human Langerhans cells

1 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells.

1 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study

1 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Ia antigen expression on human epidermal Langerhans cells

1 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermal Langerhans cells express Ia antigens

1 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermal Langerhans cells bear Fc and C3 receptors

1 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)

1 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI

1 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon

1 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Dendritic cells and cutaneous immune responses to chemical allergens

1 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

The skin immune system Its cellular constituents and their interactions

1 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture

1 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Migration and maturation of Langerhans cells in skin transplants and explants

1 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin

1 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Up-regulation of alpha 4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes

1 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response

1 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

The delineation of antigen receptors on human T lymphocytes

1 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Regulation of T-cell activation: differences among T-cell subsets

1 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cells

1 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Adhesion receptors of the immune system

1 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes

1 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice

1 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice

1 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Correlation between lymphocyte proliferative responses and dendritic cell migration in regional lymph nodes following skin painting with contact-sensitizing agents.

1 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs

1 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Immune regulation in allergic and irritant skin reactions

1 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction

1 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Differential regulation of murine T lymphocyte subsets

1 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human TH1 and TH2 subsets: doubt no more

1 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Revisiting and revising suppressor T cells

1 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones

1 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion

1 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Recombinant Gamma Interferon Induces HLA-DR Expression on Cultured Human Keratinocytes

1 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor

1 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Early cellular events in evolving cutaneous delayed hypersensitivity in humans

1 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Keratinocytes as initiators of inflammation.

1 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermal Langerhans cells are derived from cells originating in bone marrow

1 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermal cell production of thymocyte activating factor (ETAF)

1 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Keratinocyte-derived interleukin 3.

1 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Hematopoietic, lymphopoietic, and proinflammatory cytokines produced by human and murine keratinocytes

1 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity

1 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

IL-8 gene expression and production in human keratinocytes and their modulation by UVB

1 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Granulocyte colony stimulating activity derived from human keratinocytes

1 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation

1 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light

1 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Production and auto-induction of transforming growth factor-α in human keratinocytes

1 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes

1 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis

1 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human keratinocytes are a major source of cutaneous platelet-derived growth factor

1 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes.

1 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor

1 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212)

1 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1.

1 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes

1 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Membrane and Cytosolic Interleukin-1 Alpha and Beta in Normal Human Epidermal Cells: Variability of Epitope Exposure in Immunohistochemistry

1 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin-1 alpha in normal skin

1 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

1 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis

1 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

1 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Cytokines amplify the function of accessory cells

1 June 2024

88

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells

1 June 2024

89

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

In-vivo administration of interleukin 1 both enhances and suppresses contact sensitivity in the mouse

1 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function

1 June 2024

91

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture

1 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Early molecular events in the induction phase of contact sensitivity

1 June 2024

93

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells

1 June 2024

95

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

1 June 2024

98

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

1 June 2024

102

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Physiological and molecular mechanisms of lymphocyte homing

1 June 2024

106

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

ELAM-1 is an adhesion molecule for skin-homing T cells

1 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation

1 June 2024

108

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Activation-independent binding of human memory T cells to adhesion molecule ELAM-1.

1 June 2024

109

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation

1 June 2024

110

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor-alpha

1 June 2024

114

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis)

1 June 2024

117

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions

1 June 2024

118

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?

1 June 2024

120

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins

1 June 2024

122

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Effects of ultraviolet radiation on murine epidermal Langerhans cells: doses of ultraviolet radiation that modulate ICAM-1 (CD54) expression and inhibit Langerhans cell function cause delayed cytotoxicity in vitro

1 June 2024

124

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase

1 June 2024

125

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 June 2024

126

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells

1 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 June 2024

130

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin-6 and the acute phase response

1 June 2024

131

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Contact hypersensitivity induces plasma interleukin 6

1 June 2024

132

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Modulation of Langerhans cell surface antigen expression by recombinant cytokines.

1 June 2024

133

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Epidermis as a secretory tissue: an in vitro tissue model to study keratinocyte secretion

1 June 2024

134

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Langerhans cells are the major source of mRNA for IL-1 beta and MIP-1 alpha among unstimulated mouse epidermal cells

1 June 2024

137

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Activated human langerhans cells express mRNA for IL-1α and IL-1β and produce these cytokines but do not secrete them

1 June 2024

139

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines

1 June 2024

141

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores

1 June 2024

142

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation

1 June 2024

143

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biologic

1 June 2024

144

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Dog mastocytoma cells produce transforming growth factor beta 1

1 June 2024

145

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness

1 June 2024

146

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Release of leukotrienes in patients with bronchial asthma

1 June 2024

147

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion

1 June 2024

150

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice.

1 June 2024

153

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils

1 June 2024

154

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Human eosinophils express transforming growth factor alpha

1 June 2024

155

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Cytokine production by mast cells and basophils

1 June 2024

158

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

The skin immune system: progress in cutaneous biology

1 June 2024

159

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Horizons in pharmacologic intervention in allergic contact dermatitis

1 June 2024

160

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Soluble cytokine receptors: their role in immunoregulation

1 June 2024

161

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Lymphocyte function-associated antigen-1 is required for maximum elicitation of allergic contact dermatitis

1 June 2024

162

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Cytokine antagonists and their potential therapeutic use

1 June 2024

164

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 June 2024

165

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

1 June 2024

167

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 June 2024

168

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 June 2024

169

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats

1 June 2024

170

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis

1 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality

1 June 2024

173

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 June 2024

175

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model

1 June 2024

177

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Inflammatory and immunomodulatory roles of TGF-beta.

1 June 2024

178

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines

1 June 2024

179

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response

1 June 2024

180

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 June 2024

181

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 June 2024

184

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 10: a novel stimulatory factor for mast cells and their progenitors

1 June 2024

185

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 June 2024

188

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 June 2024

189

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Regulation of contact hypersensitivity by interleukin 10.

1 June 2024

191

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Induction of hapten-specific tolerance by interleukin 10 in vivo

1 June 2024

192

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions

1 June 2024

193

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity

1 June 2024

194

1 reference

https://api.crossref.org/works/10.1016/0190-9622(95)91817-5

1 June 2024

Identifiers

1 reference

20 September 2017

1 reference